IsoPlexis Corporation – NASDAQ:ISO
Founder-led company
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
IsoPlexis stock price monthly change
-29.44%
month
IsoPlexis stock price quarterly change
+1.56%
quarter
IsoPlexis stock price yearly change
-82.76%
year
IsoPlexis key metrics
Market Cap | 30.28M |
Enterprise value | 44.15M |
P/E | -0.29 |
EV/Sales | 2.63 |
EV/EBITDA | -0.46 |
Price/Sales | 1.78 |
Price/Book | 0.72 |
PEG ratio | N/A |
EPS | -2.84 |
Revenue | 16.76M |
EBITDA | -91.54M |
Income | -111.20M |
Revenue Q/Q | -65.65% |
Revenue Y/Y | -22.04% |
Profit margin | -632.41% |
Oper. margin | -575.68% |
Gross margin | -5.52% |
EBIT margin | -575.68% |
EBITDA margin | -546.16% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIsoPlexis stock price history
IsoPlexis stock forecast
IsoPlexis financial statements
| Mar 2022 | 4.91M | -29.71M | -604.97% |
|---|---|---|---|
| Jun 2022 | 4.00M | -26.84M | -670.16% |
| Sep 2022 | 4.48M | -19.94M | -444.69% |
| Dec 2022 | 3.36M | -34.71M | -1033% |
| 2022-08-10 | -0.54 | -0.65 |
|---|---|---|
| 2022-11-10 | -0.43 | -0.47 |
| 2023-03-02 | -0.39 | -0.84 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | 163.34% |
| 2022 |
| Mar 2022 | 176112000 | 61.41M | 34.87% |
|---|---|---|---|
| Jun 2022 | 152966000 | 62.39M | 40.79% |
| Sep 2022 | 134852000 | 61.34M | 45.49% |
| Dec 2022 | 109068000 | 67.80M | 62.16% |
| Mar 2022 | -31.90M | -4.55M | 7.50M |
|---|---|---|---|
| Jun 2022 | -32.36M | -1.22M | 7.58M |
| Sep 2022 | -16.89M | -1.76M | 185K |
| Dec 2022 | -15.47M | -267K | 56K |
IsoPlexis alternative data
| Aug 2023 | 290 |
|---|---|
| Sep 2023 | 290 |
| Oct 2023 | 290 |
| Nov 2023 | 290 |
| Dec 2023 | 290 |
| Jan 2024 | 290 |
| Feb 2024 | 290 |
| Mar 2024 | 290 |
| Apr 2024 | 290 |
| May 2024 | 290 |
| Jun 2024 | 290 |
| Jul 2024 | 290 |
IsoPlexis other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2021 | 1000000 | 0 |
| Aug 2022 | 95253 | 0 |
| Quarter | Transcript |
|---|---|
| Q3 2022 11 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 10 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q4 2021 2 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. Sean Mackay (1982) Co-Founder, Chief Executive Officer, Pres & Director | $530,000 |
Mr. Peter Siesel (1965) Chief Commercial Officer | $337,810 |
Mr. John R. Strahley CPA (1967) Chief Financial Officer | $325,000 |
-
When is IsoPlexis's next earnings date?
Unfortunately, IsoPlexis's (ISO) next earnings date is currently unknown.
-
Does IsoPlexis pay dividends?
No, IsoPlexis does not pay dividends.
-
How much money does IsoPlexis make?
IsoPlexis has a market capitalization of 30.28M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2.88% to 16.76M US dollars. IsoPlexis made a loss 115.5M US dollars in net income (profit) last year or -$0.84 on an earnings per share basis.
-
What is IsoPlexis's stock symbol?
IsoPlexis Corporation is traded on the NASDAQ under the ticker symbol "ISO".
-
What is IsoPlexis's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of IsoPlexis?
Shares of IsoPlexis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are IsoPlexis's key executives?
IsoPlexis's management team includes the following people:
- Mr. Sean Mackay Co-Founder, Chief Executive Officer, Pres & Director(age: 43, pay: $530,000)
- Mr. Peter Siesel Chief Commercial Officer(age: 60, pay: $337,810)
- Mr. John R. Strahley CPA Chief Financial Officer(age: 58, pay: $325,000)
-
Is IsoPlexis founder-led company?
Yes, IsoPlexis is a company led by its founder Mr. Sean Mackay.
-
How many employees does IsoPlexis have?
As Jul 2024, IsoPlexis employs 290 workers.
-
When IsoPlexis went public?
IsoPlexis Corporation is publicly traded company for more then 3 years since IPO on 8 Oct 2021.
-
What is IsoPlexis's official website?
The official website for IsoPlexis is isoplexis.com.
-
Where are IsoPlexis's headquarters?
IsoPlexis is headquartered at 35 NE Industrial Road, Branford, CT.
-
How can i contact IsoPlexis?
IsoPlexis's mailing address is 35 NE Industrial Road, Branford, CT and company can be reached via phone at +20 3 2084111.
IsoPlexis company profile:
IsoPlexis Corporation
isoplexis.comExchange:
NASDAQ
Full time employees:
290
Industry:
Medical - Devices
Sector:
Healthcare
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.
35 NE Industrial Road
Branford, CT 06405
Branford, CT 06405
CIK: 0001615055
ISIN: US4650051067
CUSIP: 465005106
